Amber Ilyas

8PUBLICATIONS
17CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyMolecular targetsCancer geneticsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 12, 2026
UBB as an early-stage potential biomarker for breast cancer via modulation of the ubiquitination pathway.

|Feb 02, 2026
miRNA-1231 Regulated EGFR Signaling: A Potential Therapeutic Target for Hepatocellular Carcinoma.

Quratul Abedin, Hira Baqai, Tehseen Fatima

|Dec 30, 2025
Gene expression analysis of diabetic foot ulcers reveals the potential impact of Levofloxacin on wound healing.

Nazia Hassan, Amber Ilyas, Muhammad Farooq Memon

|Jul 07, 2025
GSTP1, PRDX2 and NFE2L2: Potential Markers for Primary Stage Breast Cancer.

Syeda Abiha Zehra Jaffari, Fatima Haider, Nida Syed

|May 16, 2025
Identification of Potential Hub Proteins as Theragnostic Targets in Hepatocellular Carcinoma through Comprehensive Quantitative Tissue Proteomics Analysis.

Quratul Abedin, Kulsoom Bibi, Alex von Kriegsheim

|Jul 20, 2023
Differential Protein Expression in Response to Varlitinib Treatment in Oral Cancer Cell Line: an In Vitro Therapeutic Approach.

Fariha Tanveer, Amber Ilyas, Basir Syed

Pageof 2

Frequent Collaborators

3 joint publications

Zehra Hashim

3 joint publications

Fatima Haider

2 joint publications

Shamshad Zarina

2 joint publications

Syeda Nuzhat Nawab